Scientists hunt for blood clues to perfect dose for devastating lung disease
NCT ID NCT03304678
Summary
This study aimed to find clues in blood and urine that could help doctors determine the best dose of the drug sirolimus for women with LAM, a rare and progressive lung disease. Researchers followed 33 women who were starting sirolimus treatment, collecting samples after their first dose and again at 3 and 9 months. The goal was to identify biological markers that change with the drug, which could one day lead to more personalized dosing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHANGIOLEIOMYOMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.